Pamukkale University   Report issue

Academic/Hospital Phase 4
Founded: Denizli Turkey (1957)

Organization Overview

First Clinical Trial
2007
NCT01069536
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Antalya Education and Research Hospital | Mücahit ÖZTOP | Pamukkale U | Pamukkale University | PAMUKKALE UNİVERSİTY HOSPİTAL EMERGENCY MEDİCİNE | pamukkale university, Medical Faculty, PMR Department | Pamukkale University School of Physical Therapy and Rehabilitation | pamukkale universty | PhD | Serbay SEKEROZ

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Ankle Injuries (Phase 4)

Back Pain (Phase 4)

Dizziness (Phase 4)

Dysmenorrhea (Phase 4)

Dyspepsia (Phase 4)

Emergencies (Phase 4)

Fever (Phase 4)

Flank Pain (Phase 4)

Headache (Phase 4)

Infections (Phase 4)

Low Back Pain (Phase 4)

Migraine Disorders (Phase 4)

Musculoskeletal Pain (Phase 4)

Nausea (Phase 4)

Pharyngitis (Phase 4)

Respiratory Tract Infections (Phase 4)

Sciatica (Phase 4)

Sprains and Strains (Phase 4)

Urolithiasis (Phase 4)

Vertigo (Phase 4)

Vomiting (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 31
  • # of Trial APIs: 25